Effects of non-steroid antirheumatic agents on microsomal drug-metabolizing enzymes of rat liver.
D000632:Aminopyrine / Q000378:metabolism / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000378:metabolism / Q000652:urine; D001241:Aspirin / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D004790:Enzyme Induction; D005439:Flufenamic Acid / Q000494:pharmacology; D006591:Hexobarbital / Q000494:pharmacology; D066298:In Vitro Techniques; D007191:Indazoles / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D008744:Methylamines / Q000494:pharmacology; D008780:Methyltransferases / Q000378:metabolism; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D009929:Organ Size; D010088:Oxidoreductases / Q000096:biosynthesis; D010634:Phenobarbital / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D012457:Salicylamides / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects; D012980:Sodium Salicylate / Q000494:pharmacology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D007191:Indazoles; D008744:Methylamines; D011720:Pyrazoles; D012457:Salicylamides; D012459:Salicylates; D000632:Aminopyrine; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D006591:Hexobarbital; D010088:Oxidoreductases; D008780:Methyltransferases; D001205:Ascorbic Acid; D001241:Aspirin; D012980:Sodium Salicylate; D007213:Indomethacin; D010634:Phenobarbital